AVEO PHARMACEUTICALS INC's ticker is AVEO and the CUSIP is 053588109. A total of 49 filers reported holding AVEO PHARMACEUTICALS INC in Q1 2017. The put-call ratio across all filers is - and the average weighting 2.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $1,000 | -50.0% | 1,850 | -35.1% | 0.00% | – |
| Q3 2019 | $2,000 | 0.0% | 2,850 | 0.0% | 0.00% | – |
| Q2 2019 | $2,000 | 0.0% | 2,850 | +54.1% | 0.00% | – |
| Q1 2019 | $2,000 | -85.7% | 1,850 | -78.3% | 0.00% | – |
| Q4 2018 | $14,000 | -33.3% | 8,540 | +30.6% | 0.00% | – |
| Q3 2018 | $21,000 | +75.0% | 6,540 | +58.0% | 0.00% | – |
| Q2 2018 | $12,000 | 0.0% | 4,140 | 0.0% | 0.00% | – |
| Q1 2018 | $12,000 | +140.0% | 4,140 | +123.8% | 0.00% | – |
| Q4 2017 | $5,000 | -28.6% | 1,850 | 0.0% | 0.00% | – |
| Q3 2017 | $7,000 | +600.0% | 1,850 | +640.0% | 0.00% | – |
| Q2 2017 | $1,000 | – | 250 | 0.0% | 0.00% | – |
| Q1 2017 | $0 | – | 250 | 0.0% | 0.00% | – |
| Q4 2016 | $0 | – | 250 | 0.0% | 0.00% | – |
| Q3 2016 | $0 | – | 250 | +21.4% | 0.00% | – |
| Q1 2014 | $0 | – | 206 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Deer VI & Co. LLC | 675,242 | $2,465,000 | 100.00% |
| New Leaf Venture Partners, L.L.C. | 2,340,673 | $8,543,000 | 3.96% |
| RA Capital Management | 11,328,646 | $41,350,000 | 3.74% |
| NEA Management Company, LLC | 16,362,694 | $59,724,000 | 2.09% |
| Avoro Capital Advisors LLC | 4,806,249 | $17,543,000 | 1.36% |
| 683 Capital Management, LLC | 2,515,810 | $9,183,000 | 0.96% |
| SPHERA FUNDS MANAGEMENT LTD. | 1,400,000 | $5,110,000 | 0.73% |
| Perceptive Advisors | 6,830,232 | $25,110,000 | 0.48% |
| EAM Investors, LLC | 785,338 | $2,866,000 | 0.38% |
| Polar Capital LLP | 4,129,238 | $15,072,000 | 0.17% |